MedPath

Health-Related Quality of Life in Patients With Bladder Cancer

Completed
Conditions
Bladder Cancer
Registration Number
NCT00744744
Lead Sponsor
David Latini
Brief Summary

RATIONALE: Gathering information about quality of life in patients with cancer may improve the ability to plan treatment and may help patients live more comfortably.

PURPOSE: This clinical trial is studying health-related quality of life in patients with bladder cancer.

Detailed Description

OBJECTIVES:

* To identify aspects of survivorship experience that differ by clinical risk (low risk vs high risk) in patients with non-invasive bladder cancer.

* To collect and examine data on health-related quality of life (HRQOL) and symptom management.

* To analyze differences in outcomes between genders, stage and grade of disease, and recency of diagnosis (new diagnosis vs β‰₯ 6 month diagnosis).

OUTLINE: Patients undergo a 45-minute telephone interview to assess their current medical condition and psychological functioning (i.e., bladder cancer treatment history, levels of depression and anxiety, quality of life, self-efficacy, and perceived social support). Patients complete a series of questionnaires including the Lepore social constraint measure; REACH social support measure; self-report inventories assessing patient communication, relationship style, illness intrusiveness, fear of recurrence, and social constraint; Impact of Events scale; Brief Symptom Index-18 and Global Severity Index; EORTC QLQ-C30 (general health-related quality of life); and EORTC QLC-BLS24 (disease-specific health-related quality of life).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
138
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Collection and examination of data on health-related quality of life and symptom managementCross-sectional
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dan L. Duncan Cancer Center at Baylor College of Medicine

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

Dan L. Duncan Cancer Center at Baylor College of Medicine
πŸ‡ΊπŸ‡ΈHouston, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.